Table 2.
BPA Outcomes for 97 patients who completed BPA treatment and had at least three BPA sessions
| Before BPA (n = 97) | Post BPA (n = 97, 530 BPA sessions) | p Value | |
|---|---|---|---|
| sPAP (mmHg); mean ± SD | 62 ± 19.9 | 52.2 ± 17.2 | <0.001 |
| dPAP (mmHg); mean ± SD | 22 ± 6.7 | 18.3 ± 5.7 | <0.001 |
| pre mPAP (mmHg); mean ± SD | 37 ± 10.9 | 31.4 ± 9.2 | <0.001 |
| CO (L/min); mean ± SD | 5.4 ± 1.3 | 5.4 ± 1.2 | 0.9627 |
| CI (L/min/m2); mean ± SD | 2.8 ± 0.6 | 2.8 ± 0.5 | 0.8674 |
| PVR (dynes s cm−5); mean ± SD | 398.6 ± 221.4 | 304.2 ± 177.5 | <0.01 |
| NYHA functional class; n (% of total) | |||
| 1 | 1 (1%) | 15 (15%) | <0.001 |
| 2 | 26 (27%) | 53 (55%) | <0.001 |
| 3 | 66 (68%) | 29 (30%) | <0.001 |
| 4 | 4 (4%) | 0 (0%) | |
| Number of PH medications; n (% of total) | |||
| 0 | 15 (15%) | 24 (25%) | 0.12 |
| 1 | 44 (45%) | 38 (39%) | 0.38 |
| 2 | 26 (27%) | 27 (28%) | 0.87 |
| 3 | 12 (12%) | 8 (8%) | 0.34 |
| 6MWD (m); mean ± SD (n = 63) | 416.5 ± 135.1 | 453.3 ± 132.2 | <0.01 |
| NT‐proBNP (pg/ml); mean ± SD (n = 85) | 535.9 ± 878.3 | 361.6 ± 737.2 | 0.013 |
Abbreviations: BPA, balloon pulmonary angioplasty; CI, cardiac index; CO, cardiac output; dPAP, diastolic pulmonary artery pressure; mPAP, mean pulmonary artery pressure; NT‐pro BNP, N‐terminal pro‐brain natriuretic peptide; NYHA, New York Heart Association; PH, pulmonary hypertension; PVR, pulmonary vascular resistance; sPAP, systolic pulmonary artery pressure; 6MWD, six‐minute walk distance.